DK170785A - 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse - Google Patents

4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse Download PDF

Info

Publication number
DK170785A
DK170785A DK170785A DK170785A DK170785A DK 170785 A DK170785 A DK 170785A DK 170785 A DK170785 A DK 170785A DK 170785 A DK170785 A DK 170785A DK 170785 A DK170785 A DK 170785A
Authority
DK
Denmark
Prior art keywords
piperazine
substituted
preparing
compounds
procedure
Prior art date
Application number
DK170785A
Other languages
Danish (da)
English (en)
Other versions
DK170785D0 (da
Inventor
Jeffery Clifton Watkins
Arwel Wyn Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409980A external-priority patent/GB8409980D0/en
Priority claimed from GB848410865A external-priority patent/GB8410865D0/en
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK170785D0 publication Critical patent/DK170785D0/da
Publication of DK170785A publication Critical patent/DK170785A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK170785A 1984-04-17 1985-04-16 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse DK170785A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848409980A GB8409980D0 (en) 1984-04-17 1984-04-17 Organic compounds
GB848410865A GB8410865D0 (en) 1984-04-27 1984-04-27 Organic compounds

Publications (2)

Publication Number Publication Date
DK170785D0 DK170785D0 (da) 1985-04-16
DK170785A true DK170785A (da) 1985-10-18

Family

ID=26287629

Family Applications (1)

Application Number Title Priority Date Filing Date
DK170785A DK170785A (da) 1984-04-17 1985-04-16 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse

Country Status (18)

Country Link
US (2) US5399693A (un)
EP (1) EP0159889B1 (un)
JP (1) JPH0613487B2 (un)
KR (1) KR920000897B1 (un)
CA (1) CA1248531A (un)
DE (1) DE3586694T2 (un)
DK (1) DK170785A (un)
ES (1) ES8703485A1 (un)
FI (1) FI88615C (un)
GB (1) GB2157685B (un)
GR (1) GR850930B (un)
HU (1) HU198910B (un)
IE (1) IE57737B1 (un)
IL (1) IL74900A (un)
NZ (1) NZ211784A (un)
PH (1) PH23061A (un)
PL (1) PL147181B1 (un)
PT (1) PT80296B (un)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217963A (en) * 1985-05-24 1993-06-08 Ciba-Geigy Corporation Certain phosphonic acid quinoline-2-carboxylic acids, esters or amides useful for treatment of disorders responsive to N-methyl D-aspartate receptor blockade
US4906621A (en) * 1985-05-24 1990-03-06 Ciba-Geigy Corporation Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade
US4746653A (en) * 1986-02-28 1988-05-24 Ciba-Geigy Corporation Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
US4705781A (en) * 1986-10-08 1987-11-10 Giba-Geigy Corporation Method of treating cerebral ischemia using 4-(phosphono substituted lower alkyl or lower alkenyl)piperazine-2-carboxylic acids and salts, esters and amides thereof
GB8703749D0 (en) * 1987-02-18 1987-03-25 Sandoz Ltd Piperazinecarboxylic acid
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
ATE87918T1 (de) * 1988-02-19 1993-04-15 Lilly Co Eli Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5095009A (en) * 1990-04-11 1992-03-10 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
AU632362B2 (en) * 1989-09-19 1992-12-24 Merrell Dow Pharmaceuticals Inc. Nmda antagonists
US5500419A (en) * 1989-09-19 1996-03-19 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
US5194430A (en) * 1990-05-17 1993-03-16 Merrell Dow Pharmaceuticals Inc. Heterocyclic-nmda antagonists
SE9003652D0 (sv) * 1990-11-15 1990-11-15 Astra Ab New heterocyclic compounds
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
US6071901A (en) * 1994-01-04 2000-06-06 Novo Nordisk A/S Substituted dibenz[b,f]azepines and uses thereof
WO1995029892A1 (en) * 1994-04-28 1995-11-09 The Du Pont Merck Pharmaceutical Company Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
US5990307A (en) * 1997-08-01 1999-11-23 American Home Products Corporation Process for the preparation of [2-((8.9)-Dioxo-2,6-Diazabicyclo [5.2.0]-Non-1(7)-en-2yl) Ethyl]Phosphonic acid
US6916816B2 (en) 1999-12-16 2005-07-12 The Board Of Regents Of The University Of Nebraska Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents
GB9929582D0 (en) * 1999-12-16 2000-02-09 Univ Bristol Chemical compounds
JP4807675B2 (ja) * 2001-02-26 2011-11-02 東レ・ファインケミカル株式会社 高純度ピペラジン誘導体塩酸塩の製造方法
TW200514775A (en) * 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
GB201521903D0 (en) * 2015-12-11 2016-01-27 Electrophoretics Ltd Isorbaric mass labels
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
CN109134403B (zh) * 2018-09-27 2022-08-16 湖南恒泰化工有限公司 一种2-吗啉乙磺酸的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028388A (en) * 1960-01-27 1962-04-03 Sterling Drug Inc Derivatives of piperazine
DE2110568A1 (de) * 1971-03-05 1972-09-07 Merck Patent Gmbh Neue N-Acyl-(piperazinoalkyl)-pyrazole
US3751416A (en) * 1971-05-27 1973-08-07 American Cyanamid Co 3-(2-(4-phenyl-1-piperazinyl)-ethyl)indolines
BE793955A (fr) * 1972-01-15 1973-07-12 Merck Patent Gmbh Arylpiperazines et leur procede de preparation
US3899491A (en) * 1972-03-29 1975-08-12 Ciba Geigy Corp Alkyl alkanoate derivatives of substituted piperazines and polymer compositions stabilized thereby
NO131267C (un) * 1973-10-22 1975-05-07 Underhaugs Fabrikk As
SE397531B (sv) * 1973-12-28 1977-11-07 Merck Patent Gmbh Forfarande for framstellning av 1-pyrazolyl-alkyl-4-arylpiperaziner
DE2612843B2 (de) * 1976-03-26 1979-10-31 Dynamit Nobel Ag, 5210 Troisdorf Bis-acrylester und Bis-methacrylester, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung
US4089958A (en) * 1976-12-20 1978-05-16 American Home Products Corporation 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2]quinoxalin-5(6)-ones and derivatives thereof
IT1094076B (it) * 1978-04-18 1985-07-26 Acraf Cicloalchiltriazoli
US4198509A (en) * 1978-10-30 1980-04-15 E. R. Squibb & Sons, Inc. Mercaptoacylpiperazine carboxylic acid compounds
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use
GB2104078B (en) * 1981-08-14 1985-01-23 London Polytech New aminoacid isomers, their production and their medicinal use
US4400330A (en) * 1982-07-29 1983-08-23 Stauffer Chemical Company Method for preparation of N-phosphonomethylglycine
US4492651A (en) * 1983-11-23 1985-01-08 American Home Products Corporation Cyclic hexapeptides
US4906621A (en) * 1985-05-24 1990-03-06 Ciba-Geigy Corporation Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade
US4705781A (en) * 1986-10-08 1987-11-10 Giba-Geigy Corporation Method of treating cerebral ischemia using 4-(phosphono substituted lower alkyl or lower alkenyl)piperazine-2-carboxylic acids and salts, esters and amides thereof
US4880808A (en) * 1987-04-01 1989-11-14 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for improving sleep
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5095009A (en) * 1990-04-11 1992-03-10 Merrell Dow Pharmaceuticals Inc. NMDA antagonists

Also Published As

Publication number Publication date
AU578675B2 (en) 1988-11-03
JPS60231662A (ja) 1985-11-18
JPH0613487B2 (ja) 1994-02-23
DE3586694D1 (de) 1992-11-05
PT80296B (pt) 1988-03-03
EP0159889B1 (en) 1992-09-30
PL252962A1 (en) 1985-12-17
HUT37604A (en) 1986-01-23
FI88615B (fi) 1993-02-26
IE850966L (en) 1985-10-17
EP0159889A3 (en) 1986-11-12
GB2157685B (en) 1988-04-27
PH23061A (en) 1989-03-27
GR850930B (un) 1985-11-25
FI851514L (fi) 1985-10-18
IL74900A (en) 1992-11-15
EP0159889A2 (en) 1985-10-30
PL147181B1 (en) 1989-05-31
US5595983A (en) 1997-01-21
FI88615C (fi) 1993-06-10
HU198910B (en) 1989-12-28
NZ211784A (en) 1988-01-08
US5399693A (en) 1995-03-21
DE3586694T2 (de) 1993-02-18
CA1248531A (en) 1989-01-10
IE57737B1 (en) 1993-03-24
PT80296A (en) 1985-05-01
DK170785D0 (da) 1985-04-16
KR920000897B1 (ko) 1992-01-30
KR850007593A (ko) 1985-12-07
GB8509602D0 (en) 1985-05-22
ES542276A0 (es) 1987-02-16
GB2157685A (en) 1985-10-30
FI851514A0 (fi) 1985-04-16
ES8703485A1 (es) 1987-02-16
AU4121685A (en) 1985-10-24

Similar Documents

Publication Publication Date Title
DK170785D0 (da) 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK167187D0 (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK164049C (da) 1-benzyl-aminoalkyl-pyrrolidiononer, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse
DK101489D0 (da) Piperazinderivater eller salte heraf, fremgangsmaade til fremstilling af disse og farmaceutiske praeparater indeholdende saadanne forbindelser
DK362787D0 (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK206987D0 (da) Hidtil ukendte diphosphonsyreforbindelser, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse forbindelser
DK241585D0 (da) 8-chlor-quinolincarboxylsyre-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK183986D0 (da) Cyklopentylaetere, fremgangsmaade til fremstilling deraf og laegemiddelpraeparat indeholdende saadanne forbindelser
DK187785D0 (da) Chartreusinderivater og salte deraf, fremgangsmaade til fremstillingaf disse og antitumorpraeparater indeholdende saadanne forbindelser
DK457787D0 (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK307085A (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK163512C (da) Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne
DK591983D0 (da) 1-phenyllavalkyl-1h-1,2,3-triazolforbindelser og salte deraf samt farmaceutiske praeparater indeholdende disse forbindelser og fremgangsmade til fremstilling deraf
DK106287D0 (da) Glycero-3(2)-phospho-l-serin-derivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK158518C (da) Phenylpiperazinderivater og syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt praeparater indeholdende derivaterne
DK457985A (da) 5-fluor-2 -deoxyuridinderivater og salte heraf, fremgangsmaade til fremstilling af disse samt antitumorpraeparater indeholdende disse praeparater
DK610084A (da) Imidazolderivater eller syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK597184D0 (da) Substituerede spiro-pyridinderivater, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af saadanne forbindelser
DK605186D0 (da) 16,17-acetalsubstituerede pregnan-21-ionsyrederivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DK163247C (da) Gonadolibeinderivater, farmaceutisk acceptable syreadditionssalte og complexer heraf samt en fremgangsmaade til fremstilling af disse og et farmaceutisk praeparat indeholdende disse
DK245787D0 (da) Nicotinsyrederivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater
DK164453C (da) Dibenzooeb,daathiopyran-6-carboxylsyreforbindelser, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed
AHB Application shelved due to non-payment